Exact Mass: 518.0388

Exact Mass Matches: 518.0388

Found 23 metabolites which its exact mass value is equals to given mass value 518.0388, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Dithiazanine iodide

3,3-Diethylthiadicarbocyanine iodide

C23H23IN2S2 (518.0347)

D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D004396 - Coloring Agents > D005456 - Fluorescent Dyes

(-)-4beta-(2-hydroxyethylsulfanyl)epicatechin 3-O-gallate

C24H22O11S (518.0883)

swertiabisxanthone-I

C26H14O12 (518.0485)

(4R)-9c-acetoxy-9a-hydroxy-4-hydroxymethyl-12,4,4,5xi-tetramethyl-(6ac,8cO,9ac,2rC7)-tetrahydro-spiro[4r,10ac-azaethano-cyclopenta[4,5]pyrrolo[2,1-d][1,2,3,5]trithiazepine-8,2-furan]-5,11,3-trione|(5Xi)-sirodesmin-C|Sirodesmin C

(4R)-9c-acetoxy-9a-hydroxy-4-hydroxymethyl-12,4,4,5xi-tetramethyl-(6ac,8cO,9ac,2rC7)-tetrahydro-spiro[4r,10ac-azaethano-cyclopenta[4,5]pyrrolo[2,1-d][1,2,3,5]trithiazepine-8,2-furan]-5,11,3-trione|(5Xi)-sirodesmin-C|Sirodesmin C

C20H26N2O8S3 (518.0851)

Regorafenib Hydrochloride (BAY 73-4506 hydrochloride) is a multi-target inhibitor for VEGFR1/2/3, PDGFRβ, Kit, RET and Raf-1 with IC50s of 13/4.2/46, 22, 7, 1.5 and 2.5 nM, respectively[1].

Briciclib sodium

C19H21Na2O10PS (518.0388)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

quercetin 3-O-beta-D-(1-O-malonyl)-xylopyranoside

C23H18O14-2 (518.0697)

Cefminox anion

C16H20N7O7S3- (518.0586)

butyl 3-[(5Z)-5-[3-(3-butoxy-3-oxopropyl)-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]propanoate

C20H26N2O6S4 (518.0674)

4-bromo-1-({9-bromo-6-methyl-10-oxo-11-oxatricyclo[4.3.2.0¹,⁵]undecan-4-yl}methyl)-3,3-dimethylcyclohexyl acetate

C22H32Br2O4 (518.0667)

(1'r,2s,3's,4's,5r,7'r,10'r)-3'-hydroxy-10'-(hydroxymethyl)-4,4,5,15'-tetramethyl-3,9',14'-trioxo-11',12',13'-trithia-8',15'-diazaspiro[oxolane-2,5'-tetracyclo[8.3.2.0¹,⁸.0³,⁷]pentadecan]-4'-yl acetate

(1'r,2s,3's,4's,5r,7'r,10'r)-3'-hydroxy-10'-(hydroxymethyl)-4,4,5,15'-tetramethyl-3,9',14'-trioxo-11',12',13'-trithia-8',15'-diazaspiro[oxolane-2,5'-tetracyclo[8.3.2.0¹,⁸.0³,⁷]pentadecan]-4'-yl acetate

C20H26N2O8S3 (518.0851)

3'-hydroxy-10'-(hydroxymethyl)-4,4,5,15'-tetramethyl-3,9',14'-trioxo-11',12',13'-trithia-8',15'-diazaspiro[oxolane-2,5'-tetracyclo[8.3.2.0¹,⁸.0³,⁷]pentadecan]-4'-yl acetate

C20H26N2O8S3 (518.0851)

(1r,4r)-4-bromo-1-{[(1r,4r,5s,6s,9r)-9-bromo-6-methyl-10-oxo-11-oxatricyclo[4.3.2.0¹,⁵]undecan-4-yl]methyl}-3,3-dimethylcyclohexyl acetate

C22H32Br2O4 (518.0667)

(1'r,2r,3's,4's,7'r,10'r)-3'-hydroxy-10'-(hydroxymethyl)-4,4,5,15'-tetramethyl-3,9',14'-trioxo-11',12',13'-trithia-8',15'-diazaspiro[oxolane-2,5'-tetracyclo[8.3.2.0¹,⁸.0³,⁷]pentadecan]-4'-yl acetate

(1'r,2r,3's,4's,7'r,10'r)-3'-hydroxy-10'-(hydroxymethyl)-4,4,5,15'-tetramethyl-3,9',14'-trioxo-11',12',13'-trithia-8',15'-diazaspiro[oxolane-2,5'-tetracyclo[8.3.2.0¹,⁸.0³,⁷]pentadecan]-4'-yl acetate

C20H26N2O8S3 (518.0851)